Editorial Solving the Mystery of Nitrate Tolerance
A New Scent on the Trail? Ho-Leung Fung, PhD In a recent review on nitrate tolerance, Packer' stated, somewhat pessimistically although correctly, that "despite intensive study during the last 100 years, the cause of nitrate tolerance remains a mystery." Multiple mechanisms appear to be involved, and "the relative importance of one pathway versus another may not be constant but may depend on the status of the patient, as well as the dose, duration, and route of administration of the nitrate being utilized."' The mystery is, however, highly worthy of solution, not only because of its intellectual and scientific challenge, but also because of the tremendous therapeutic benefits that we can gain with nitrates if the tolerance problem can be understood and resolved.
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Multiple Mechanisms of Nitrate Tolerance When isolated blood vessels are incubated with millimolar concentrations of nitroglycerin (NTG) over a short period of time (up to an hour), there is a rightward shift of the concentration-response curve to NTG and other nitrates, indicating tolerance. There has been no shortage of possible mechanisms to explain this in vitro phenomenon. These mechanisms all involve possible changes in the cellular biochemistry after nitrate exposure. The oldest of these explanations is the "sulfhydryl depletion hypothesis,"2 which states that "organic nitrates react with reduced sulfhydryl groups in the vascular smooth muscle receptor leading to the formation of a disulfide linkage." Tolerance is presumably brought about by conversion of "the nitrate receptor to the disulfide form, which presumably has a lower affinity for NTG." This hypothesis is supported by numerous studies showing that an exogenous supply of free thiol can enhance nitrate potency and partially reverse nitrate tolerance both in vitro and in vivo,3 although to date, no NTG receptor per se has been identified.
More recent studies have shown that instead of a direct interaction with cellular receptors, nitrates are enzymatically converted in the blood vessels to nitric oxide,45 which interacts with the enzyme guanylate cyclase to produce cyclic GMP (cGMP), thereby causing vasorelaxation. Knowledge of the biochemical pathway of nitrate action leads to the evolvement of other cellular theories of in vitro vascular nitrate tolerance. The "sulfhydryl depletion hypothesis" has been modified to suggest that tolerance is caused by a reduction of available sulfhydryl groups necessary for the metabolic activation of nitrates. 6 Other mechanisms suggest that nitrate tolerance could be brought about by a reduction of vascular production of nitric oxide from NTG,7 a decrease in the vascular metabolism to its dinitrate metabolites, 8,9 or a molecular alteration of the cellular soluble guanylate cyclase.'0 These cellular mechanisms of nitrate tolerance, although attractive for explaining the in vitro phenomenon, have been found inappropriate or inadequate for the in vivo situation. First, the conditions that are used to cause vascular nitrate tolerance in vitro are quite different from those in vivo: Millimolar concentrations of NTG are exposed to isolated blood vessels in vitro, whereas systemic NTG concentrations found in patients are in the nanomolar range." Tolerance develops within 30 minutes to 1 hour under in vitro conditions, whereas nitrate effects generally last for several hours before tolerance is evident in patients. Second, it is difficult to conceive how these cellular biochemical mechanisms can be used to explain the clinical phenomena of nitrate resistance12 and withdrawal rebound,13 both of which appear to relate more to physiological regulation than cellular metabolism. It is therefore no surprise that investigators begin to look for alternative mechanisms that are more oriented to the systemic interaction of nitrates rather than only their cellular effects.
A number of studies have now appeared that show chronic nitrate administration to be accompanied by a variety of compensatory physiological effects. Among these are the increased plasma concentrations of neurohormones (eg, renin, catecholamines), increased body weight and sodium retention, and shifts in vascular volumes.'4-'6 These findings suggest that in vivo nitrate tolerance might be brought about more by physiological counterregulation rather than by a change in the cellular biochemistry of the blood vessels.
The dichotomy of whether nitrate tolerance has a "cellular" versus a "systemic" origin need not be resolved by choosing one over the other. In fact, the study by Watanabe et al17 in this issue of Circulation suggests that they may be interrelated. These investigators showed that when patients who have no prior nitrate exposure were injected with an intracoronary dose of NTG, significant increases in platelet cGMP and coronary artery diameters were seen. However, when patients who have been exposed to chronic isosorbide dinitrate were treated similarly, the increases in platelet cGMP and coronary artery diameters were considerably reduced. These data showed, apparently for the first time, that clinical nitrate tolerance (as exhibited by the lack of response in coronary dilation) was paralleled by profound changes in cellular events (viz, reduced platelet cGMP production).
What Are the Mechanistic and Clinical Implications of These Results? Although these data do not directly suggest that similar cellular changes also occur in the vascular smooth muscle cells, the apparent similarity in the biochemistry of nitrates in these two cellular systems would indicate that in vivo nitrate tolerance could also alter nitrate biochemistry in the vasculature. The validity of this extrapolation would require experimental confirmation.
Another interesting implication of the study by Watanabe et al17 may relate to the chronic effects of nitrates in the treatment of unstable angina. It is now clear that the antiplatelet effects of NTG may play an important role in this therapy18 and that these effects are primarily mediated through the production of cGMP. 19 Although clinical tolerance to nitrates in patients with stable angina pectoris and congestive heart failure is well documented,20 tolerance to the antiplatelet effects of nitrates upon chronic administration has not been clearly demonstrated. The results of Watanabe et al17 would therefore suggest that clinical tolerance to nitrates in unstable angina is also likely. Their study should stimulate others to conduct prospective trials to test this important hypothesis.
Would platelet cGMP be a useful indicator of nitrate action and tolerance? The answer is probably yes. Presently, there are methodological limitations in quantifying clinical nitrate tolerance serially in various patient populations. In patients with stable angina, repeated exercise testing to the development of chest pain cannot be performed too frequently. In patients with congestive heart failure, invasive catheterization cannot be maintained for several days simply for the sake of investigation. The availability of a "nitrate tolerance" index that is capable of easy and repeated access would undoubtedly be of advantage to investigators in this field.
What Precautions Must Be Taken in Interpreting
These Data?
Because of the study design of Watanabe et al,17 the interesting implications just stated will have to be tempered with some reservations, several of which have already been mentioned in that study. The study population is small, and further validation with a larger group of patients is needed. The patient characteristics and other concomitant drug treatments were also substantially different between the "nitrate" versus the "nonitrate" groups. A potentially confounding factor is that two thirds of the patients in the nitrate group had received calcium channel blockers. Although these medications were discontinued at least 48 hours before the study, the residual effects of calcium channel blockade and its impact on platelet function cannot be ignored. A better design would have involved the same patients in a prospective, randomized crossover study in which the ability of the platelets to produce cGMP is examined with or without prior nitrate exposure.
Another potential limitation is the use of the intracoronary route for administering the challenge dose of NTG. This is obviously not a common route of clinical nitrate dosing, and it is at present uncertain whether the same results can be reproduced with other routes of administration that are more common clinically (viz, sublingual, intravenous, oral, or transdermal).
What Questions Are Raised by the Study of
Watanabe et al? Despite these precautions, the present study does raise several important questions regarding the mechanisms of action and clinical application of nitrates. If attenuation in the platelet biochemical apparatus to generate cGMP does occur with chronic nitrate dosing, what is the mechanism? Does it involve depletion of critical sulfhydryl groups? Can exogenous sulfhydryl supplementation avoid this attenuation? (Information already exists showing that sulfhydryl donors such as N-acetylcysteine can potentiate the antiplatelet action of nitrovasodilators.19) Is nitric oxide production also decreased? Does this attenuation occur with other nitrovasodilators (eg, with nitroprusside and S-nitrosothiols)? If systemic tolerance to the hemodynamic effects of nitrates is avoided, for example, by using angiotensin converting enzyme inhibitors2' or hydralazine,22 would the attenuation in platelet cGMP production be also abolished? Are there correlations between the time courses and extents of tolerance development in systemic hemodynamic effects and those in platelet cGMP production? Answers to these questions would greatly enhance our understanding of nitrate action and tolerance.
Like the solution of any good mystery, the delineation of the mechanism(s) of nitrate tolerance has been led, and sometimes misled, by the many scents that appear on the trail. Some of these scents will confuse our sense of direction, but invariably they do stimulate our curiosity and sharpen our perception. The study by Watanabe et al'7 no doubt represents another valuable scent that leads toward the understanding of the causes of nitrate tolerance; time will tell how much it will help us in sniffing out the true mechanism or mechanisms of this interesting and important phenomenon.
